Gene deletion, or inhibition of IL-10 or TGF-β with neutralizing antibodies, aggravates atherosclerosis in mice and exacerbates effector Th1 and Th2 responses [77,78,79]. This evidence concerns the gene TGFB1 and atherosclerosis.